Loading grant details…
I-Corps: Multiplexed paper-based test for rapid diagnosis of early-stage Lyme Disease
| Funder | National Science Foundation (US) |
|---|---|
| Recipient Organization | University of California-Los Angeles |
| Country | United States |
| Start Date | Mar 01, 2021 |
| End Date | Mar 31, 2022 |
| Duration | 395 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | National Science Foundation (US) |
| Grant ID | 2055749 |
Grant Description
The broader impact/commercialization potential of this I-Corps project is the development of a low-cost rapid diagnostic tool with the ability to measure multiple health markers in a single test.
Development of this platform may benefit the healthcare system by improving the accessibility of diagnostic and prognostic testing that requires a panel of measurements. Specifically, there is potential for an early-stage Lyme disease (LD) diagnostic. Approximately 300,000 people contract LD each year, incurring a $1.3 billion cost to the medical system.
Unfortunately, much of the societal and economic costs of LD stem from misdiagnosis due to the low sensitivity of the current Centers for Disease Control (CDC)-recommended testing protocol, which is typically
All Grantees
University of California-Los Angeles
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Related Grants
